Jesy Nelson has shared her mixed emotions regarding the groundbreaking move to screen newborns for a severe muscle wasting disease. The former member of the group Little Mix expressed uncertainty about her twins’ future as doctors evaluate the extent of muscle loss they experienced before their delayed diagnosis and treatment. Jesy had advocated for nationwide testing for spinal muscular atrophy (SMA) after her twin daughters, Ocean and Story, were diagnosed too late, leading to irreversible nerve damage and a prognosis of never being able to walk.
Following the government’s decision to screen all newborns in England for SMA, Jesy described the development as both amazing and bittersweet. She emphasized the importance of early detection, highlighting that if the issue had been addressed earlier, her daughters might not be facing their current challenges. SMA, caused by a defective SMN1 gene, hinders the production of a crucial protein that supports nerve cells responsible for transmitting signals between the brain, spinal cord, and muscles.
The twins, Ocean and Story, undergo regular assessments at Great Ormond Street Hospital in London to determine the remaining motor neuron function and potential salvageability since commencing treatment. Jesy expressed concern about the decline in their test results and the possibility of returning to treatment, noting the uncertainty surrounding their condition. Despite receiving gene therapy and requiring ongoing medication to boost protein production, the twins’ prognosis remains uncertain due to the delayed diagnosis.
Jesy’s journey, including her advocacy efforts and her daughters’ medical challenges, is documented in the upcoming Prime Video series “Jesy Nelson: Life Changing.” The decision to implement SMA screening for newborns is a significant milestone, offering hope for improved outcomes for future children. Jesy’s ultimate goal is for her daughters to realize the impact of their story on positive change and to feel empowered by their unique journey.
As the Mirror continues its coverage of the SMA testing issue, Jesy expressed gratitude for the platform’s support in raising awareness. The announcement of nationwide screening for SMA was welcomed by Aoife Regan, director at Great Ormond Street Hospital Charity, emphasizing the importance of specialized care for children with SMA and their families following a challenging diagnosis.